Bio-Diagnostics

Executive Summary

Bio-Diagnostics is a UK-based biotechnology company specialized in diagnostics, with a focus on immunology, allergy, dermatology, and immunohistochemistry. Founded in 1995, it offers a broad portfolio including rapid antibody tests, allergy diagnostics, and autoimmune testing, alongside contract manufacturing, laboratory services, and distribution. The company operates from a fully regulated UK facility certified to EN ISO 13485 and GMP standards, ensuring high-quality production and compliance. Its long-standing presence and comprehensive capabilities position it as a reliable partner in the diagnostics sector. As a private company with limited public disclosures, Bio-Diagnostics' growth trajectory is underpinned by the rising demand for point-of-care and specialized diagnostics, particularly in allergy and autoimmune testing. Its established certifications and niche focus provide a competitive edge, though market expansion and product innovation will be key to capturing new opportunities. While near-term catalysts are not clearly defined, the company's strong regulatory foundation and operational expertise suggest potential for strategic partnerships or product line extensions. The conviction score reflects a solid but unexciting outlook, given the lack of recent milestones or financial data.

Upcoming Catalysts (preview)

• Q3 2026Launch of New Allergy Diagnostic Panel60% success
• 2026Expansion into European Markets via Distribution Partnerships50% success
• TBDMajor Contract Manufacturing Agreement with a Biopharma Partner40% success